BJL
GOSS icon

Brighton Jones LLC’s Gossamer Bio GOSS Stock Holding History

Brighton Jones LLC’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.32K Buy
32,308
+12,240
+61% +$3.42K ﹤0.01% 1419
2026
Q1 		$6.59K Buy
+20,068
New +$31.5K ﹤0.01% 1200
2025
Q4 		– Sell
-13,754
Closed -$36.2K – 410
2025
Q3 		$36.2K Buy
+13,754
New +$30.3K ﹤0.01% 1011

Other funds holding GOSS

CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MGW
MB Generational Wealth Spokane, Washington $204M AUM 25.77% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Brighton Jones LLC's GOSS Position: Q2 2026 in Review

Brighton Jones LLC increased its Gossamer Bio (GOSS) stake by 61% in Q2 2026, buying an estimated $3.42K and bringing the position to 32,308 shares worth $5.32K. The position accounts for ﹤0.01% of the portfolio, ranked #1419.

Brighton Jones LLC first reported a position in GOSS in Q3 2025 and has held it in 3 quarters since. The position peaked at $36.2K in Q3 2025. 78 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Brighton Jones LLC held 32,308 shares of Gossamer Bio worth $5.32K as of Q2 2026.
  • Brighton Jones LLC bought 12,240 Gossamer Bio shares in Q2 2026, an estimated $3.42K.
  • Gossamer Bio made up ﹤0.01% of Brighton Jones LLC's portfolio in Q2 2026, its #1419 holding.
  • Brighton Jones LLC first reported a position in Gossamer Bio in Q3 2025 and has held it in 3 quarters since.
  • Brighton Jones LLC's Gossamer Bio position peaked at $36.2K in Q3 2025.
  • 78 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Brighton Jones LLC's 13F filing for Q2 2026, filed 11 Aug 2026.